Search results for "Sarcopenia"

showing 10 items of 159 documents

Prevalence of Sarcopenia in Community-Dwelling Older Adults in Valencia, Spain.

2020

This study is an observational and cross-sectional study on the prevalence of sarcopenic disease in 202 autonomous older adults

Malemedicine.medical_specialtySarcopeniaHealth Toxicology and MutagenesisprevalenceShort Physical Performance Batterylcsh:MedicineDiseaseMuscle massArticlesarcopeniaolder people03 medical and health sciencesGrip strength0302 clinical medicinemedicineHumans030212 general & internal medicineGeriatric Assessmentolder adultsAgedEuropean Working Group on Sarcopenia in Older People 2 (EWGSOP2)Aged 80 and overHand Strengthbusiness.industrylcsh:RPublic Health Environmental and Occupational Healthmedicine.diseasemusculoskeletal systemGait speedbody regionsCross-Sectional StudiesSpainSarcopeniaPhysical therapymuscle strengthObservational studyFemaleIndependent LivingOlder peoplebusinesshuman activities030217 neurology & neurosurgeryInternational journal of environmental research and public health
researchProduct

Differential influence of peripheral and systemic sex steroids on skeletal muscle quality in pre- and postmenopausal women

2011

Aging is associated with gradual decline of skeletal muscle strength and mass often leading to diminished muscle quality. This phenomenon is known as sarcopenia and affects about 30% of the over 60-year-old population. Androgens act as anabolic agents regulating muscle mass and improving muscle performance. The role of female sex steroids as well as the ability of skeletal muscle tissue to locally produce sex steroids has been less extensively studied. We show that despite the extensive systemic deficit of sex steroid hormones in postmenopausal compared to premenopausal women, the hormone content of skeletal muscle does not follow the same trend. In contrast to the systemic levels, muscle t…

Muscle tissue0303 health sciencesAgingmedicine.medical_specialtyeducation.field_of_studyPopulationDehydroepiandrosteroneSkeletal muscle030209 endocrinology & metabolismCell BiologyBiologymedicine.disease03 medical and health sciences0302 clinical medicineEndocrinologymedicine.anatomical_structureSarcopeniaInternal medicinemedicineAndrostenedioneeducationTestosterone030304 developmental biologyHormoneAging Cell
researchProduct

Importance of sarcopenia parameter changes after living donor liver transplantation

2017

The systemic role of muscle tissue is strengthened by the large system of hormones, chemokines and other mediators that constitute a dense network of communication between the skeletal muscle and the liver (1,2). This, associated with the evidence of a progressive malnutrition and depletion of muscle mass in end-stage liver disease (ESLD) patients, has led many to study the role of sarcopenia and its systemic effects in this setting, and to identify it as critical risk factor for post- liver transplantation (LT) mortality (3-5). Englesbe and colleagues found a direct correlation between central sarcopenia, measured by computerized tomography (CT), the total area of the psoas muscle (psoas a…

Muscle tissueChemokinePathologymedicine.medical_specialtybiologybusiness.industrySkeletal muscle030230 surgerymedicine.disease03 medical and health sciences0302 clinical medicinemedicine.anatomical_structureSarcopenia Liver TransplantationSarcopeniamedicinebiology.protein030211 gastroenterology & hepatologyLiving donor liver transplantationbusinessLetter to the EditorHormone
researchProduct

Prognostic Value of Sarcopenia in Metastatic Colorectal Cancer Patients Treated with Trifluridine/Tipiracil

2021

Sarcopenia is common in metastatic colorectal cancer (mCRC), increases the risk of treatment-related toxicity and reduces survival. Trifluridine/tipiracil (TT) chemotherapy significantly improved survival in refractory mCRC patients, but the prognostic and predictive role of pretherapeutic sarcopenia and variation in the skeletal muscle index (SMI) during this treatment has not been investigated so far. In this retrospective, observational study, clinical data on mCRC patients treated with TT at six cancer centres in Poland were collected. Computed tomography (CT) scans acquired at the time of initiation of TT (CT1) and on the first restaging (CT2), were evaluated. SMI was assessed based on…

Oncologymedicine.medical_specialtyColorectal cancermedicine.medical_treatmentTrifluridineArticletrifluridine/tipiracilsarcopeniachemistry.chemical_compoundCarcinoembryonic antigenInternal medicineMedicineTipiracilChemotherapyPerformance statusbiologybusiness.industrymetastatic colorectal cancerRCancerGeneral Medicinemedicine.diseasechemistrySarcopeniabiology.proteinMedicinebusinessmedicine.drugcancer cachexiaJournal of Clinical Medicine
researchProduct

Influence of cachexia and sarcopenia on survival in pancreatic ductal adenocarcinoma: a systematic review.

2014

Abstract Background/objectives Cachexia affects ∼80% of pancreatic cancer patients. An international consensus defines cachexia as an ongoing loss of skeletal muscle mass (sarcopenia) with or without loss of fat, which impairs body functioning and cannot be reversed by conventional nutritional measures. Weight loss percentage and elevated inflammation markers have been employed to define this condition earlier. This review aimed to assess the prevalence and consequences of cachexia and sarcopenia on survival in patients with pancreatic ductal adenocarcinoma. Methods The systematic review was performed by searching the articles with preset terms published in PubMed and Cochrane Database unti…

Oncologymedicine.medical_specialtySarcopeniaCachexiaEndocrinology Diabetes and MetabolismOverweightCachexiaWeight lossInternal medicinePancreatic cancerWeight LossmedicinePrevalenceHumansSarcopenic obesityHepatologybusiness.industryConfoundingGastroenterologymedicine.diseasePrognosismusculoskeletal systemPancreatic NeoplasmsSurvival RateCachexia/diagnosis/epidemiology/*etiology; Carcinoma Pancreatic Ductal/*complications/mortality; Humans; Pancreatic Neoplasms/*complications/mortality; Prevalence; Prognosis; Sarcopenia/diagnosis/epidemiology/*etiology; Survival Rate; Weight LossSarcopeniaAdenocarcinomamedicine.symptombusinessCarcinoma Pancreatic Ductal
researchProduct

Effect of Oral Beta-Hydroxy-Beta-Methylbutyrate (HMB) Supplementation on Physical Performance in Healthy Old Women Over 65 Years: An Open Label Rando…

2015

Although older people are particularly liable to sarcopenia, limited research is available on beta-hydroxy-beta-methylbutyrate (HMB) supplementation in this population, particularly in healthy subjects. In this parallel-group, randomized, controlled, open-label trial, we aimed to evaluate whether an oral supplement containing 1.5 g of calcium HMB for 8 weeks could improve physical performance and muscle strength parameters in a group of community-dwelling healthy older women. Eighty healthy women attending a twice-weekly mild fitness program were divided into two equal groups of 40, and 32 of the treated women and 33 control completed the study. We considered a change in the Short Physical …

OralGenetics and Molecular Biology (all)medicine.medical_specialtyAbsorptiometry Photon; Administration Oral; Aged; Aged 80 and over; Female; Humans; Valerates; Dietary Supplements; Hand Strength; Physical Fitness; Agricultural and Biological Sciences (all); Biochemistry Genetics and Molecular Biology (all); Medicine (all)Strength trainingPopulationPhysical fitnessAdministration Orallcsh:MedicineIsometric exerciseBiochemistrynot knownlaw.inventionAbsorptiometry PhotonRandomized controlled triallawHand strength80 and overValeratesmedicineHumansAbsorptiometrylcsh:ScienceeducationAgedAged 80 and overGeriatricseducation.field_of_studyMultidisciplinaryHand Strengthbusiness.industryMedicine (all)lcsh:Rmedicine.diseasePhotonAgricultural and Biological Sciences (all)Physical FitnessSarcopeniaAdministrationDietary SupplementsPhysical therapyFemalelcsh:Qbusinesshuman activitiesResearch ArticlePLOS ONE
researchProduct

Assessment of maximal handgrip strength: how many attempts are needed?

2017

© 2017 The Authors. Background: Handgrip strength (HGS) is used to identify individuals with low muscle strength (dynapenia). The influence of the number of attempts on maximal HGS is not yet known and may differ depending on age and health status. This study aimed to assess how many attempts of HGS are required to obtain maximal HGS. Methods: Three cohorts (939 individuals) differing in age and health status were included. HGS was assessed three times and explored as continuous and dichotomous variable. Paired t-test, intraclass correlation coefficients (ICC) and Bland-Altman analysis were used to test reproducibility of HGS. The number of individuals with misclassified dynapenia at attemp…

Pathologymedicine.medical_specialtyIntraclass correlationCross-sectional studybusiness.industrymedicine.disease03 medical and health sciencesGrip strength0302 clinical medicinePhysiology (medical)SarcopeniaHand strengthmedicineMuscle strengthOrthopedics and Sports Medicine030212 general & internal medicineYoung adultbusiness030217 neurology & neurosurgeryDemographyCohort studyJournal of Cachexia, Sarcopenia and Muscle
researchProduct

Vitamin D and the Elderly Orthopedic Patient

2017

Abstract Vitamin D is a key player in calcium homeostasis and bone health. Beyond these well-known effects, new data suggest that vitamin D deficiency potentiates a variety of chronic disease states, including diabetes, cancer, and depression. Extremely low vitamin D levels have been associated with osteomalacia and impaired muscle function, both core elements in the field of orthopedic surgery. Good muscle function and healthy bones are essential for fast rehabilitation and positive outcome after orthopedic surgery as well, especially for elderly patients seeking good physical function. Physical function is important for the preservation of independence in daily life and for the prevention…

Pediatricsmedicine.medical_specialtyOsteomalaciaRehabilitationbusiness.industrymedicine.medical_treatmentmedicine.diseasevitamin D deficiencyDiabetes mellitusSarcopeniaOrthopedic surgerymedicineVitamin D and neurologyPhysical therapybusinessDepression (differential diagnoses)
researchProduct

Treating cancer in older and oldest old patients.

2015

The so-called “silver tsunami” is a metaphor that the individuals 65 and older represent the most rapidly growing segment of the Western world population. Aging is an ongoing process that leads to the loss of functional reserve of multiple organ systems, increased susceptibility to stress, it is associated with increased prevalence of chronic disease, and functional dependence. Determined by a combination of genetic and environmental factors, this process is highly individualized and poorly reflected in chronologic age. The heterogeneity and the complexity of the older old population represent the main challenge to the treatment of cancer in those patients. We should discern "fit" elderly i…

PharmacologyGerontologyAged 80 and overeducation.field_of_studybusiness.industryPopulationAge FactorsCancermedicine.diseaseOldest oldolder patientsSettore MED/40 - GINECOLOGIA E OSTETRICIAChronic diseaseSarcopeniaNeoplasmsDrug DiscoverymedicinecancerWestern worldHumansMeaning (existential)educationbusinessOrgan systemCurrent pharmaceutical design
researchProduct

Mitochondrial biogenesis in health and disease. Molecular and therapeutic approaches.

2014

Mitochondrial biogenesis (MB) is the essential mechanism by which cells control the number of mitochondria. Cells respond to different physiologic, metabolic, and pathologic changes by regulating this organelle with high morphological and functional adaptability. A considerable number of proteins, transcription factors, upstream regulatory proteins and secondary mechanisms are involved in MB and the stabilization of new mitochondrial DNA. These MB activators and regulators, including the main participating proteins (e.g. PGC-1α and mtTFA), are candidates for therapeutic intervention in diverse diseases, like neurodegenerative disorders, metabolic syndrome, sarcopenia, cardiac pathophysiolo…

PharmacologyMitochondrial DNAMitochondrial DiseasesMechanism (biology)Health StatusDiseaseBiologyTFAMMitochondrionBioinformaticsmedicine.diseaseCell biologyMitochondriaMitochondrial biogenesisSarcopeniaDrug DiscoverymedicineAnimalsHumansEnergy MetabolismTranscription factorSignal TransductionTranscription FactorsCurrent pharmaceutical design
researchProduct